Cooper Companies, Inc. (The) (COO) Shares Sold by State of Alaska Department of Revenue

State of Alaska Department of Revenue reduced its position in Cooper Companies, Inc. (The) (NYSE:COO) by 1.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,081 shares of the medical device company’s stock after selling 65 shares during the period. State of Alaska Department of Revenue’s holdings in Cooper Companies, Inc. (The) were worth $1,455,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of COO. Fox Run Management L.L.C. acquired a new stake in Cooper Companies, Inc. (The) during the first quarter worth approximately $876,000. Private Trust Co. NA increased its stake in Cooper Companies, Inc. (The) by 75.0% in the first quarter. Private Trust Co. NA now owns 5,421 shares of the medical device company’s stock valued at $1,083,000 after buying an additional 2,323 shares in the last quarter. Capstone Asset Management Co. purchased a new stake in Cooper Companies, Inc. (The) during the first quarter valued at about $269,000. Bank of Montreal Can increased its stake in Cooper Companies, Inc. (The) by 11.6% in the first quarter. Bank of Montreal Can now owns 32,885 shares of the medical device company’s stock valued at $6,573,000 after buying an additional 3,414 shares in the last quarter. Finally, WCM Investment Management CA increased its stake in Cooper Companies, Inc. (The) by 0.9% in the first quarter. WCM Investment Management CA now owns 261,445 shares of the medical device company’s stock valued at $52,260,000 after buying an additional 2,223 shares in the last quarter. 99.97% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies, Inc. (COO) traded up 0.39% during trading on Friday, reaching $240.92. The company had a trading volume of 286,217 shares. The company has a 50-day moving average of $245.26 and a 200-day moving average of $214.46. Cooper Companies, Inc. has a 52-week low of $158.73 and a 52-week high of $256.39. The firm has a market capitalization of $11.77 billion, a P/E ratio of 36.12 and a beta of 0.61.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.25 by $0.25. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. The business had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. During the same period last year, the business posted $2.05 earnings per share. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. Analysts expect that Cooper Companies, Inc. will post $9.63 EPS for the current fiscal year.

The firm also recently announced a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were given a $0.03 dividend. This represents a yield of 0.02%. The ex-dividend date was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is currently 0.90%.

TRADEMARK VIOLATION WARNING: “Cooper Companies, Inc. (The) (COO) Shares Sold by State of Alaska Department of Revenue” was reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2017/08/11/state-of-alaska-department-of-revenue-decreases-position-in-cooper-companies-inc-the-coo-updated-updated-updated.html.

Several equities research analysts have weighed in on COO shares. BMO Capital Markets restated an “outperform” rating and set a $255.00 price target (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a report on Monday, June 5th. Zacks Investment Research raised Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 price objective for the company in a research report on Wednesday, May 3rd. Jefferies Group LLC reaffirmed a “buy” rating and set a $250.00 price objective (up from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Stifel Nicolaus upped their target price on Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, June 2nd. Finally, Guggenheim assumed coverage on Cooper Companies, Inc. (The) in a research report on Thursday, June 29th. They issued a “neutral” rating for the company. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Cooper Companies, Inc. (The) has a consensus rating of “Buy” and a consensus target price of $242.00.

In related news, VP Randal Golden sold 1,621 shares of Cooper Companies, Inc. (The) stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total transaction of $394,956.65. Following the completion of the sale, the vice president now owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Paul L. Remmell sold 9,294 shares of Cooper Companies, Inc. (The) stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the sale, the chief executive officer now directly owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The disclosure for this sale can be found here. In the last ninety days, insiders sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is owned by insiders.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

What are top analysts saying about Cooper Companies Inc. (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cooper Companies Inc. (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit